ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.

Neurooncol Adv · 2023 · PMC10540884 · PMID 37781087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Dividing the cohort into high and low ABL1/2 expression groups, tumors with high ABL1 expression showed a nonsignificant trend for worse overall survival (OS) in the SHH molecular subgroup ( Supplementary Figure 1A ), whereas tumors with high ABL2 expression showed a nonsignificant trend for worse overall survival in the SHH and group 3 molecular subgroups ( Supplementary Figure1B ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.